RWMG
CLGN icon

Redwood Wealth Management Group’s CollPlant Biotechnologies CLGN Stock Holding History

Redwood Wealth Management Group’s Portfolio CLGN Stock Details CLGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,310
Closed -$6.51K – 338
2024
Q2 		$6.51K Buy
+1,310
New +$7.27K ﹤0.01% 681

Other funds holding CLGN

PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
AE
AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return
BEI
Benjamin Edwards Inc Clayton, Missouri $10.1B AUM 14.03% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Redwood Wealth Management Group's CLGN Position: Q3 2024 in Review

Redwood Wealth Management Group sold out of CollPlant Biotechnologies (CLGN) in Q3 2024, closing a stake of 1,310 shares — an estimated $6.51K sold.

Redwood Wealth Management Group first reported a position in CLGN in Q2 2024 and held it in 1 quarter. The position peaked at $6.51K in Q2 2024. 13 funds tracked by Wall St. Rank hold CLGN as of Q3 2024.

  • Redwood Wealth Management Group reported no remaining CollPlant Biotechnologies position as of Q3 2024 after selling out during the quarter.
  • Redwood Wealth Management Group sold 1,310 CollPlant Biotechnologies shares in Q3 2024, an estimated $6.51K.
  • Redwood Wealth Management Group first reported a position in CollPlant Biotechnologies in Q2 2024 and held it in 1 quarter.
  • Redwood Wealth Management Group's CollPlant Biotechnologies position peaked at $6.51K in Q2 2024.
  • 13 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q3 2024.

Based on Redwood Wealth Management Group's 13F filing for Q3 2024, filed 13 Nov 2024.